Susquehanna International Group
SVA

Susquehanna International Group’s Sinovac Biotech, Ltd SVA Stock Holding History

Susquehanna International Group’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-19,300
Closed -$148K – 10793
2018
Q3 		$148K Sell
19,300
-21,400
-53% -$154K ﹤0.01% 8428
2018
Q2 		$304K Sell
40,700
-7,700
-16% -$60.6K ﹤0.01% 7824
2018
Q1 		$417K Buy
48,400
+2,000
+4% +$16.5K ﹤0.01% 7000
2017
Q4 		$366K Buy
+46,400
New +$347K ﹤0.01% 7224
2014
Q3 		– Sell
-12,100
Closed -$68K – 10671
2014
Q2 		$68K Sell
12,100
-9,300
-43% -$56.5K ﹤0.01% 9541
2014
Q1 		$154K Buy
+21,400
New +$142K ﹤0.01% 8405
2013
Q4 		– Sell
-76,000
Closed -$454K – 9858
2013
Q3 		$454K Buy
76,000
+18,400
+32% +$88K ﹤0.01% 6576
2013
Q2 		$226K Buy
+57,600
New +$214K ﹤0.01% 7268

Other funds holding SVA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
NAH
Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HI
Horizon Investments Charlotte, North Carolina $8.92B AUM 25.62% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Susquehanna International Group's SVA Position: Q1 2026 in Review

Susquehanna International Group held its Sinovac Biotech, Ltd (SVA) position steady in Q1 2026 at 16,430 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #12304.

Susquehanna International Group first reported a position in SVA in Q4 2013 and has held it in 37 quarters since. The position peaked at $402K in Q1 2018. 28 funds tracked by Wall St. Rank hold SVA as of Q1 2026.

  • Susquehanna International Group held 16,430 shares of Sinovac Biotech, Ltd worth $106K as of Q1 2026.
  • Susquehanna International Group left its Sinovac Biotech, Ltd share count unchanged in Q1 2026.
  • Sinovac Biotech, Ltd made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12304 holding.
  • Susquehanna International Group first reported a position in Sinovac Biotech, Ltd in Q4 2013 and has held it in 37 quarters since.
  • Susquehanna International Group's Sinovac Biotech, Ltd position peaked at $402K in Q1 2018.
  • 28 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.